速递｜爱美客：公司“司美格鲁肽注射液”项目目前处于临床试验阶段

Group 1 - The core viewpoint of the article is that Aimeike (300896.SZ) is currently in the clinical trial phase for its "Semaglutide Injection" project [1]. Group 2 - The article mentions that the "GLP-1 Club" consists of hundreds of professionals and serves as a primary choice for industry experts to gain insights into the GLP-1 industry chain [6]. - The club offers various resources such as lectures, academic promotions, and consulting services to its members [7].